MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients

Haematologica. 2019 Jan;104(1):e25-e28. doi: 10.3324/haematol.2018.195958. Epub 2018 Jun 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Cyclophosphamide / administration & dosage
  • Disease-Free Survival
  • Doxorubicin / administration & dosage
  • Female
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • Lymphoma, B-Cell* / drug therapy
  • Lymphoma, B-Cell* / mortality
  • Lymphoma, B-Cell* / pathology
  • Male
  • Middle Aged
  • Prednisone / administration & dosage
  • Proto-Oncogene Proteins c-myc / biosynthesis*
  • Rituximab / administration & dosage
  • Survival Rate
  • Vincristine / administration & dosage

Substances

  • MYC protein, human
  • Proto-Oncogene Proteins c-myc
  • R-CHOP protocol
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone